Henry Schein Inc (HSIC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Henry Schein Inc (Henry Schein) is a provider of health care products and services for dental and medical practitioners. Its product portfolio consists of preventatives, infection-control products, composites, anesthetics, dental implants, generic and branded drugs, vaccines, surgical products and diagnostic tests, among others. It also offers technology solutions such as practice management software, and e-commerce solutions, equipment repair, financial services and other value-added services. The company serves dental practitioners, laboratories and physician practices, government, institutional healthcare clinics and other alternate care clinics. It operates in Germany, France, Canada, Switzerland, the UK, and the US, among others. Henry Schein is headquartered in New York, the US.Henry Schein Inc Key Recent Developments
- May 21, 2024: Henry Schein to Present at Investor Conferences in June 2024
- May 07, 2024: Henry Schein Reports Solid First-Quarter 2024 Financial Results and Updates 2024 Financial Guidance
- May 03, 2024: Henry Schein Orthodontics Demonstrates Latest Aligner Solutions to Help Enhance Patient Treatment Plans at American Association of Orthodontics Meeting
- Apr 10, 2024: Henry Schein Announces Appointment of Three New Members to the Company’s Executive Management Committee
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Section 1 - About the Company
Section 2 - Company Analysis
Section 3 - Company Financial Ratios
Section 4 - Company’s Lifesciences Financial Deals and Alliances
Section 5 - Company’s Recent Developments
Section 6 - Appendix
List of Tables
List of Figures
Samples
LOADING...
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- LocalMed Inc
- Benco Dental Supply Company
- Cencora Inc
- VYNE Therapeutics Inc
- Veradigm LLC
- ProSites, Inc.
- Proclinic SA
- McKesson Corp
- Good Methods Global Inc
- GACD Group
- eClinicalWorks LLC
- Pluradent AG & Co KG
- ZocDoc Inc
- Weave Communications Inc
- Solutionreach Inc
- Patterson Companies Inc
- Cardinal Health Inc
- Planmeca Oy
- Epic Systems Corp
- Carestream Health Inc
- NextGen Healthcare Inc
- Medline Industries LP
- Lifco publ AB
- DD Products and Services Ltd